Julio Wainstein
Overview
Explore the profile of Julio Wainstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1888
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Bar-Dayan Y, Wainstein J, Schorr L, Derazne E, Schorr Y, Jakubowicz D, et al.
Eur J Intern Med
. 2018 Dec;
60:13-17.
PMID: 30503083
Objective: To examine the association between hypoglycemic events and inpatient and outpatient mortality rates, and to characterize the profile of patients with diabetes who develop hypoglycemia during hospitalization in order...
22.
Ludvik B, Frias J, Tinahones F, Wainstein J, Jiang H, Robertson K, et al.
Lancet Diabetes Endocrinol
. 2018 Feb;
6(5):370-381.
PMID: 29483060
Background: Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors improve glycaemic control and reduce bodyweight in patients with type 2 diabetes through different mechanisms. We assessed the safety...
23.
Bar-Dayan Y, Shotashvily T, Boaz M, Wainstein J
Am J Ther
. 2017 Nov;
24(6):e701-e705.
PMID: 29099732
The cost effectiveness of generic drugs has promoted their use worldwide. However, the large variety of bioequivalent generic and brand-name drugs found in the marketplace increases the complexity and frequency...
24.
Jakubowicz D, Wainstein J, Landau Z, Ahren B, Barnea M, Bar-Dayan Y, et al.
J Nutr Biochem
. 2017 Sep;
49:1-7.
PMID: 28863364
Acute studies show that addition of whey protein at breakfast has a glucose-lowering effect through increased incretin and insulin secretion. However, whether this is a long-term effect in Type 2...
25.
Landau Z, Abiri S, Lebenthal Y, Jakubowicz D, Mor N, Lerner-Geva L, et al.
Obes Res Clin Pract
. 2017 Aug;
12(1):85-92.
PMID: 28838814
Background: Lifestyle weight loss interventions represent the mainstay of treating children with obesity. Long-term follow-up studies of intervention programs are scarce. This study assessed the long-term effects and identified factors...
26.
Jakubowicz D, Wainstein J, Landau Z, Raz I, Ahren B, Chapnik N, et al.
Diabetes Care
. 2017 Aug;
40(11):1573-1579.
PMID: 28830875
Objective: The circadian clock regulates glucose metabolism by mediating the activity of metabolic enzymes, hormones, and transport systems. Breakfast skipping and night eating have been associated with high HbA and...
27.
Elman K, Wainstein J, Boaz M, Jakubowicz D, Bar-Dayan Y
Int J Clin Pract
. 2017 Aug;
71(8).
PMID: 28758307
Background: Screening and early diagnosis of prediabetes and diabetes can prevent or delay disease onset and complications. To that end, a free public health station was established in a large,...
28.
Shimonov M, Leibou L, Davidov E, Bernadsky O, Wainstein J, Leibovitz E
Isr Med Assoc J
. 2017 May;
18(7):401-403.
PMID: 28471561
Background: Helicobacter pylori (HP) infection of the gastric mucosa may be involved in the development of insulin resistance (IR). Objectives: To investigate the association between HP status in stomach biopsies...
29.
Engel S, Suryawanshi S, Stevens S, Josse R, Cornel J, Jakuboniene N, et al.
Diabetes Obes Metab
. 2017 Apr;
19(11):1587-1593.
PMID: 28432745
Aims: To characterize the incidence of diabetes-associated complications and assess the safety of sitagliptin in participants with chronic kidney disease (CKD) in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)....
30.
Cornel J, Bakris G, Stevens S, Alvarsson M, Bax W, Chuang L, et al.
Diabetes Care
. 2016 Oct;
39(12):2304-2310.
PMID: 27742728
Objective: To evaluate chronic kidney disease (CKD) and cardiovascular outcomes in TECOS (Clinical trial reg. no. NCT00790205, clinicaltrials.gov) participants with type 2 diabetes and cardiovascular disease treated with sitagliptin, a...